These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38425090)

  • 21. [Diuretic therapy in congestive heart failure--new views on spironolactone therapy].
    Haller C
    Ther Umsch; 2000 Jun; 57(6):374-9. PubMed ID: 10894022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diuretic therapy in heart failure].
    Splendiani G; Condò S
    G Ital Nefrol; 2006; 23 Suppl 34():S74-6. PubMed ID: 16634001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of tolvaptan in heart failure patients with sustained volume overload despite the use of conventional diuretics: a phase III open-label study.
    Fukunami M; Matsuzaki M; Hori M; Izumi T;
    Cardiovasc Drugs Ther; 2011 Dec; 25 Suppl 1():S47-56. PubMed ID: 22120093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-world evidence of the effects of sodium-glucose co-transporter 2 inhibitors on the dosing of diuretics in patients with heart failure: a retrospective cohort study.
    Alsalem A; Alsultan MM; Alqarni F; Almangour A; Alsharekh L; Alenazi S; Alzahrani S; Almanqour RA; Alazmi A; Alzahrani A
    Front Pharmacol; 2024; 15():1366439. PubMed ID: 38628646
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanisms and prediction of short-term natriuretic effect of sodium-glucose cotransporter 2 inhibitor in heart failure patients coexisting type 2 diabetes mellitus.
    Fukuoka S; Dohi K; Takeuchi T; Moriwaki K; Ishiyama M; Omori T; Fujimoto N; Ito M
    Heart Vessels; 2020 Sep; 35(9):1218-1226. PubMed ID: 32270357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of loop diuretics with thiazide-type diuretics in heart failure.
    Jentzer JC; DeWald TA; Hernandez AF
    J Am Coll Cardiol; 2010 Nov; 56(19):1527-34. PubMed ID: 21029871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of the effect of thiazide derivatives by carbonic anhydrase inhibitors: molecular mechanisms and potential clinical implications.
    Zahedi K; Barone S; Xu J; Soleimani M
    PLoS One; 2013; 8(11):e79327. PubMed ID: 24260196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SGLT-2 Inhibitors: Potential Novel Strategy to Prevent Congestive Heart Failure in Diabetes?
    Verbrugge FH; Vangoitsenhoven R; Mullens W; Van der Schueren B; Mathieu C; Tang WHW
    Curr Cardiovasc Risk Rep; 2015 Aug; 9(8):. PubMed ID: 38994329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
    Mullens W; Dauw J; Martens P; Verbrugge FH; Nijst P; Meekers E; Tartaglia K; Chenot F; Moubayed S; Dierckx R; Blouard P; Troisfontaines P; Derthoo D; Smolders W; Bruckers L; Droogne W; Ter Maaten JM; Damman K; Lassus J; Mebazaa A; Filippatos G; Ruschitzka F; Dupont M;
    N Engl J Med; 2022 Sep; 387(13):1185-1195. PubMed ID: 36027559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the Cardiovascular Benefits of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: Expanding Horizons Beyond Diabetes Management.
    Fatima A; Rasool S; Devi S; Talha M; Waqar F; Nasir M; Khan MR; Ibne Ali Jaffari SM; Haider A; Shah SU; Sapna F; Varrassi G; Khatri M; Kumar S; Mohamad T
    Cureus; 2023 Sep; 15(9):e46243. PubMed ID: 37908957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Therapeutic Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in the Context of Ischemic Heart Failure: A State-of-the-Art Review.
    Gitto M; Vrachatis DA; Condorelli G; Papathanasiou K; Reimers B; Deftereos S; Stefanini GG
    Cardiovasc Hematol Agents Med Chem; 2022; 20(2):90-102. PubMed ID: 34370645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SGLT2 inhibitor and loop diuretic induce different vasopressin and fluid homeostatic responses in nondiabetic rats.
    Masuda T; Ohara K; Vallon V; Nagata D
    Am J Physiol Renal Physiol; 2022 Sep; 323(3):F361-F369. PubMed ID: 35900341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of acetazolamide in the management of diuretic resistance.
    Gill D; Gadela NV; Azmeen A; Jaiswal A
    Proc (Bayl Univ Med Cent); 2020 Oct; 34(1):169-171. PubMed ID: 33456189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natriuresis-guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium-based treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial.
    Ter Maaten JM; Beldhuis IE; van der Meer P; Krikken JA; Coster JE; Nieuwland W; van Veldhuisen DJ; Voors AA; Damman K
    Eur J Heart Fail; 2022 Feb; 24(2):385-392. PubMed ID: 34791756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.
    Ter Maaten JM; Martens P; Damman K; Dickstein K; Ponikowski P; Lang CC; Ng LL; Anker SD; Samani NJ; Filippatos G; Cleland JG; Zannad F; Hillege HL; van Veldhuisen DJ; Metra M; Voors AA; Mullens W
    Clin Res Cardiol; 2020 Aug; 109(8):1048-1059. PubMed ID: 32002631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology of diuretics.
    Brater DC
    Am J Med Sci; 2000 Jan; 319(1):38-50. PubMed ID: 10653443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial.
    Martens P; Dauw J; Verbrugge FH; Nijst P; Meekers E; Augusto SN; Ter Maaten JM; Damman K; Mebazaa A; Filippatos G; Ruschitzka F; Tang WHW; Dupont M; Mullens W
    Circulation; 2023 Jan; 147(3):201-211. PubMed ID: 36335479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Balancing diuretic therapy in heart failure: loop diuretics, thiazides, and aldosterone antagonists.
    Paul S
    Congest Heart Fail; 2002; 8(6):307-12. PubMed ID: 12461320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure.
    Faselis C; Arundel C; Patel S; Lam PH; Gottlieb SS; Zile MR; Deedwania P; Filippatos G; Sheriff HM; Zeng Q; Morgan CJ; Wopperer S; Nguyen T; Allman RM; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2020 Aug; 76(6):669-679. PubMed ID: 32762901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lessons learned from the DAPA-HF trial concerning the mechanisms of benefit of SGLT2 inhibitors on heart failure events in the context of other large-scale trials nearing completion.
    Packer M
    Cardiovasc Diabetol; 2019 Oct; 18(1):129. PubMed ID: 31585532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.